|
|||||
|
|
| Latest Insider Trading | Top Insider Trading Recent Week | Top 10% Owner Trading Recent Week | Filter
|
| Ticker | Owner | Relationship | Date | Transaction | Cost |
#Shares | Value ($) | #Shares Total | SEC Form 4 |
|---|---|---|---|---|---|---|---|---|---|
| EBAY | Sweetnam Jordan Douglas Bradle | SVP, Chief Commercial Officer | Nov 18 '25 | Sale | 82.04 | 1,006 | 82,532 | 3,868 | Nov 20 04:22 PM |
| EBAY | JORDAN SWEETNAM | Officer | Nov 18 '25 | Proposed Sale | 82.16 | 1,006 | 82,653 | Nov 18 04:19 PM | |
| EBAY | Sweetnam Jordan Douglas Bradle | SVP, Chief Commercial Officer | Nov 15 '25 | Option Exercise | 0.00 | 4,321 | 0 | 7,183 | Nov 18 04:13 PM |
| EBAY | Sweetnam Jordan Douglas Bradle | SVP, Chief Commercial Officer | Nov 04 '25 | Option Exercise | 57.71 | 34,444 | 1,987,763 | 38,167 | Nov 06 04:21 PM |
| EBAY | Sweetnam Jordan Douglas Bradle | SVP, Chief Commercial Officer | Nov 04 '25 | Sale | 81.54 | 35,305 | 2,878,777 | 2,862 | Nov 06 04:21 PM |
| EBAY | JORDAN SWEETNAM | Officer | Nov 04 '25 | Proposed Sale | 82.77 | 35,305 | 2,922,195 | Nov 04 04:35 PM | |
| EBAY | Sweetnam Jordan Douglas Bradle | SVP, Chief Commercial Officer | Sep 15 '25 | Option Exercise | 0.00 | 3,611 | 0 | 5,615 | Sep 17 04:23 PM |
| EBAY | Sweetnam Jordan Douglas Bradle | SVP, Chief Commercial Officer | Aug 15 '25 | Option Exercise | 0.00 | 4,321 | 0 | 4,321 | Aug 19 04:14 PM |
| EBAY | Sweetnam Jordan Douglas Bradle | SVP, Chief Commercial Officer | Jul 15 '25 | Sale | 77.90 | 22,206 | 1,729,847 | 0 | Jul 17 04:39 PM |
| EBAY | Sweetnam Jordan Douglas Bradle | SVP, Chief Commercial Officer | Jul 01 '25 | Sale | 75.04 | 22,207 | 1,666,413 | 22,206 | Jul 03 01:01 PM |
| EBAY | Sweetnam Jordan Douglas Bradle | SVP, Chief Commercial Officer | Jun 17 '25 | Sale | 77.38 | 23,597 | 1,825,936 | 44,413 | Jun 18 04:11 PM |
| EBAY | Sweetnam Jordan Douglas Bradle | SVP, Chief Commercial Officer | Jun 15 '25 | Option Exercise | 0.00 | 143,485 | 0 | 143,485 | Jun 17 04:09 PM |
Join thousands of traders who make more informed decisions with our premium features. Real-time quotes, advanced visualizations, backtesting, and much more.
Learn more about FINVIZ*Elite